Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia

International Journal of Hematology

Volumn 99, Issue 3, 2014, Pages 305-310

  Dimitriou, Helen ^a   Choulaki, Christianna ^a   Perdikogianni, Chryssoula ^a   Stiakaki, Eftichia ^a   Kalmanti, Maria ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Acute lymphoblastic leukemia; Asparagine synthetase; Bone marrow microenvironment; Children; Mesenchymal stromal cells

Indexed keywords

ASPARTATE AMMONIA LIGASE; MESSENGER RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLONOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; CELL CULTURE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; STEM CELL NICHE;

ASPARTATE-AMMONIA LIGASE; CELLS, CULTURED; CHILD; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MESENCHYMAL STROMAL CELLS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RNA, MESSENGER; STEM CELL NICHE; UP-REGULATION;

EID: 84899455259     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-014-1509-y     Document Type: Article

References (12)

1. Capizzi RL, Bertino JR, Skeel RT. L-asparaginase: clinical, biochemical, pharmacological and immunological status. Ann Int Med. 1971;74:893-901.
2. Pieters R, Appel I, Kuehnel H-J, Tetzlaff-Fohr I, Pichlmeier U, van der Vaart I, et al. Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new trial untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial. Blood. 2008;112:4832-8.
3. Cooney DA, Capizzi RL, Handshumacher RE. Evaluation of L-asparagine metabolism in animals and man. Cancer Res. 1970;30:929-35.
4. Chen H, Pan YX, Dudenhausen EE, Kilberg MS. Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive bZIP transcription factors as well as localized histone acetylation. J Biol Chem. 2004;279:50829-39. (Pubitemid 40017821)
5. Iwamoto S, Mihara K, Downing JR, Pui C-H, Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest. 2007;117:1049-57. (Pubitemid 46556761)
6. Hao L, Sun H, Wang J, Wang T, Wang M, Zou Z. Mesenchymal Stromal cell therapy: besides supporting hematopoiesis. Int J Hematol. 2012;95:34-46.
7. Dimitriou H, Perdikogianni Ch, Martimianaki G, Choumerianou D, Pelagiadis J, Kalmanti M. Are mesenchymal stromal cells from children resistant to apoptosis? Cell Prolif. 2009;42:276-83.
8. Appel IM, den Boer ML, Meijerink JPP, Veerman AJP, Reniers NCM, Pieters R. Up-regulation of asparagine synthetase expression is not linked to the leukemia clinical response L-asparaginase in pediatric acute lymphoblastic. Blood. 2006;107:4244-9. (Pubitemid 43801347)
9. Meijerink J, Mandigers C, van de Locht L, Tonissen E, Goodsaid F, Raemakers A. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. J Mol Diagn. 2001;3:55-61. (Pubitemid 32440243)
10. Fine BM, Kaspers GJ, Ho M, Loonen AH, Boxer LM. A genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia. Cancer Res. 2005;65:291-9. (Pubitemid 40070821)
11. Su N, Pan Y-X, Zhou M, Harvey RC, Hunger SP, Kilberg MS. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines. Pediatr Blood Cancer. 2008;50:274-9.
12. Dubbers A, Wurthwein G, Muller HJ, Schulze-Westhoff P, Winkelhorst M, Kurzknabe E, et al. Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity. Br J Haematol. 2000;109:427-9. (Pubitemid 30350729)